Skip to main content

Table 2 Minimal recurrent regions altered in MPNSTs (n = 7)

From: DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH

Cytoband

Aberration

Start clone

End clone

Size (Mb)

Frequency

Observation

1q21.1

Gain

RP3-365I19

RP11-544O24

1.2

3/7

1 sample with +1q

1q24.1-q24.2

Gain

RP11-525G13

RP4-780M13

3.7

5/7

1 sample with +1q

1q24.3-q25.1

Gain

RP1-127D3

RP5-830A10

3.5

5/7

1 sample with +1q

2p15-p14

Gain

RP11-52F10

RP11-263L17

3.0

3/7

1 sample with +2p

2q11.2-q13

Gain

RP11-451C2

RP11-368A17

11.0

4/7

1 sample with +2q

3p26.2-p25.1

Gain

RP11-95E11

RP11-255O19

12.6

4/7

1 sample with +3, 1 sample with +3p

3p22.1-p21.1

Gain

RP11-437N10

RP11-122D19

11.5

3/7

1 sample with +3, 1 sample with +3p

3q27.2-q29

Gain

RP11-110C15

RP11-23M2

12.5

3/7

1 sample with +3

5p14.3

Gain

RP11-28P24

RP11-374E21

2.0

3/7

1 sample with +5

5q34-q35.3

Gain

CTC-320C6

RP11-281O15

15.2

4/7

1 sample with +5

6p22.1-p12.1

Gain

RP11-373N24

RP11-472M19

28.1

3/7

1 sample with +6p

6p12.1-q12

Gain

RP3-422B11

RP11-349P19

7.8

3/7

1 sample with +6p, 1 sample with +6q

7p21.2-p14.1

Gain

RP11-512E16

RP5-1178G13

26.3

3/7

1 sample with +7

7q11.23-q21.11

Gain

RP11-313P13

RP5-1057M1

7.4

4/7

1 sample with +7, 1 sample with +7q

8p23.1-p12

Gain

RP11-540E4

RP11-473A17

22.9

5/7

2 samples with +8

8q11.23-q24.3

Gain

RP11-53M11

RP5-1056B24

90.5

3/7

2 samples with +8

9p24.3-p23

Gain

RP11-48M17

RP11-413D24

11.6

3/7

1 sample with +9p

9p22.3-p21.2

Loss

RP11-490C5

RP11-20P5

12.8

3/7

2 samples with -9p

9q21.32-q22.33

Gain

RP11-541F16

RP11-192E23

16.0

4/7

 

9q34.11-q34.13

Gain

RP11-202H3

RP11-143H20

1.0

5/7

 

11p13

Loss

RP1-316D7

RP4-607I7

1.5

4/7

 

11q22.3-q23.1

Loss

RP11-2I22

RP11-11N15

7.7

3/7

 

11q23.2-q23.3

Loss

RP11-212D19

RP11-142I2

7.0

3/7

 

12p13.32-p13.31

Gain

RP11-543P15

RP11-277E18

4.8

3/7

1 sample with +12

12q12-q13.11

Gain

RP11-333D23

RP11-89H19

9.3

3/7

1 sample with +12

12q13.3-q15

Gain

RP11-474N8

RP11-101K2

14.2

4/7

1 sample with +12

12q21.2-q21.31

Gain

RP11-26L7

RP11-268A19

3.3

3/7

1 sample with +12

12q22

Gain

RP11-24I19

RP11-372G13

0.8

3/7

1 sample with +12

12q22-q23.3

Gain

RP11-410A13

RP11-415D21

9.1

3/7

1 sample with +12

13q12.11-q12.12

Gain

RP11-76K19

RP11-760M1

3.9

3/7

1 sample with +13

13q13.1-q14.3

Gain

RP11-141M1

RP11-327P2

18.5

3/7

1 sample with +13

13q22.1-q22.2

Gain

RP11-552M6

RP11-332E3

2.1

4/7

1 sample with +13

14q21.3-q23.3

Loss

RP11-346L24

RP11-430G13

15.3

3/7

 

14q24.3-q32.33

Gain

RP11-61F4

RP11-417P24

27.9

3/7

1 sample with +14

16p13.3-p13.2

Gain

RP11-344L6

RP11-148F10

7.9

4/7

2 samples with +16

16p13.12-p13.11

Gain

RP11-82O18

RP11-489O1

0.9

4/7

2 samples with +16

16q21-q23.2

Gain

RP11-148F12

RP11-437L22

18.2

3/7

2 samples with +16

17q23.2-q25.3

Gain

RP11-112J9

RP11-567O16

26.2

5/7

 

19p13.3-p13.2

Gain

CTB-31C16

RP11-492L14

4.9

4/7

2 samples with +19p

22q12.3-q13.2

Gain

LL22NC01-132D12

RP3-437M21

6.1

3/7